Home
/ CanBas
/ Competitors

CanBas Competitors and Similar CompaniesClear all

CanBas's competitors and similar companies include CureVac, Tosk and Polaris Pharmaceuticals.

	CanBas CanBas (キャンバス) is a drug discovery company engaged in research and development of anti-cancer agents.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.	Polaris Pharmaceuticals Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies.
Founding Date	Founding Date 2000	Founding Date 2000	Founding Date 2008	Founding Date 2006
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations HQ	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Mountain View, US HQ Sunnyvale, US	Locations San Diego, US HQ Vacaville, US
Employees	Employees 13	Employees 82517% decrease	Employees 109% decrease	Employees 26
Valuation ($)	Valuation ($) 109.6 m	Valuation ($) 648.3 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €535.2m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €9.7m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €534.4m (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income (¥1.2b) (FY, 2025)	Net income €162.2m (FY, 2024)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.1b	Total funding raised $ 8.6m	Total funding raised N/A